| Prof. Dr. Siegfried Knasmüller | Institute for Tumor Biology-Cancer Research, University Vienna / Austria |
| Prof. Dr. med. C. Unger | Director Clinics for Tumor Biology, University Freiburg / Germany |
| Dr. Bernhard Matter | Novartis, Basel/Switzerland (r.) |
| Dr. Herbert Müsch | Solvay Pharmaceuticals, Hannover / Germany |